Neuroprotection in glaucoma: A model for nouroprotection in optic neuropathies

Tania Sibila Marcic, David Anthony Belyea, Barrett Katz

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose of review: Efforts to discover modalities and pathophysiologies that might afford successful neurorescue, neurorestoration, and neuroprotection of cells of the central nervous system have focused on processes that affect the central nervous system proper, that is, the brain. Often overlooked in the search for neural protection is the fact that the mammalian optic nerve behaves in many ways as an integral part of the central nervous system. As such, the eye-the optic nerve and retina-affords an ideal clinical model for neuroprotection and neuroprotective agents. Glaucomatous optic neuropathy is the most prevalent of all adult optic neuropathies, and offers an ideal primate and lower mammalian animal model for investigations of neuroprotection. Recent findings: This is especially compelling because while recent studies in glaucoma have shown reduction of intraocular pressure (IOP) to be an effective modality in the treatment of glaucomatous opt c neuropathy, not all patients respond to or can achieve meaningful IOP reductions. Therefore much attention has now been focused on neuroprotection as a strategy in therapies for glaucomatous optic neuropathy as a means of preserving retinal ganglion cells and their axonal projections. Summary: This review discusses the latest studies on various mechanisms of neuroprotection in the treatment of glaucomatous optic neuropathy.

Original languageEnglish (US)
Pages (from-to)353-356
Number of pages4
JournalCurrent Opinion in Ophthalmology
Volume14
Issue number6
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Optic Nerve Diseases
Glaucoma
Central Nervous System
Optic Nerve
Intraocular Pressure
Retinal Ganglion Cells
Neuroprotective Agents
Primates
Retina
Neuroprotection
Therapeutics
Animal Models
Brain

Keywords

  • Apoptosis
  • Axon
  • Glaucoma
  • Neurodegeneration
  • Neuroprotection
  • Neurorepair
  • Neurorescue
  • Neurorestoration
  • Optic nerve
  • Retinal ganglion cell

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Neuroprotection in glaucoma : A model for nouroprotection in optic neuropathies. / Marcic, Tania Sibila; Belyea, David Anthony; Katz, Barrett.

In: Current Opinion in Ophthalmology, Vol. 14, No. 6, 12.2003, p. 353-356.

Research output: Contribution to journalArticle

Marcic, Tania Sibila ; Belyea, David Anthony ; Katz, Barrett. / Neuroprotection in glaucoma : A model for nouroprotection in optic neuropathies. In: Current Opinion in Ophthalmology. 2003 ; Vol. 14, No. 6. pp. 353-356.
@article{0d7e7c0d3a47438899931a1aa7187d90,
title = "Neuroprotection in glaucoma: A model for nouroprotection in optic neuropathies",
abstract = "Purpose of review: Efforts to discover modalities and pathophysiologies that might afford successful neurorescue, neurorestoration, and neuroprotection of cells of the central nervous system have focused on processes that affect the central nervous system proper, that is, the brain. Often overlooked in the search for neural protection is the fact that the mammalian optic nerve behaves in many ways as an integral part of the central nervous system. As such, the eye-the optic nerve and retina-affords an ideal clinical model for neuroprotection and neuroprotective agents. Glaucomatous optic neuropathy is the most prevalent of all adult optic neuropathies, and offers an ideal primate and lower mammalian animal model for investigations of neuroprotection. Recent findings: This is especially compelling because while recent studies in glaucoma have shown reduction of intraocular pressure (IOP) to be an effective modality in the treatment of glaucomatous opt c neuropathy, not all patients respond to or can achieve meaningful IOP reductions. Therefore much attention has now been focused on neuroprotection as a strategy in therapies for glaucomatous optic neuropathy as a means of preserving retinal ganglion cells and their axonal projections. Summary: This review discusses the latest studies on various mechanisms of neuroprotection in the treatment of glaucomatous optic neuropathy.",
keywords = "Apoptosis, Axon, Glaucoma, Neurodegeneration, Neuroprotection, Neurorepair, Neurorescue, Neurorestoration, Optic nerve, Retinal ganglion cell",
author = "Marcic, {Tania Sibila} and Belyea, {David Anthony} and Barrett Katz",
year = "2003",
month = "12",
doi = "10.1097/00055735-200312000-00006",
language = "English (US)",
volume = "14",
pages = "353--356",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Neuroprotection in glaucoma

T2 - A model for nouroprotection in optic neuropathies

AU - Marcic, Tania Sibila

AU - Belyea, David Anthony

AU - Katz, Barrett

PY - 2003/12

Y1 - 2003/12

N2 - Purpose of review: Efforts to discover modalities and pathophysiologies that might afford successful neurorescue, neurorestoration, and neuroprotection of cells of the central nervous system have focused on processes that affect the central nervous system proper, that is, the brain. Often overlooked in the search for neural protection is the fact that the mammalian optic nerve behaves in many ways as an integral part of the central nervous system. As such, the eye-the optic nerve and retina-affords an ideal clinical model for neuroprotection and neuroprotective agents. Glaucomatous optic neuropathy is the most prevalent of all adult optic neuropathies, and offers an ideal primate and lower mammalian animal model for investigations of neuroprotection. Recent findings: This is especially compelling because while recent studies in glaucoma have shown reduction of intraocular pressure (IOP) to be an effective modality in the treatment of glaucomatous opt c neuropathy, not all patients respond to or can achieve meaningful IOP reductions. Therefore much attention has now been focused on neuroprotection as a strategy in therapies for glaucomatous optic neuropathy as a means of preserving retinal ganglion cells and their axonal projections. Summary: This review discusses the latest studies on various mechanisms of neuroprotection in the treatment of glaucomatous optic neuropathy.

AB - Purpose of review: Efforts to discover modalities and pathophysiologies that might afford successful neurorescue, neurorestoration, and neuroprotection of cells of the central nervous system have focused on processes that affect the central nervous system proper, that is, the brain. Often overlooked in the search for neural protection is the fact that the mammalian optic nerve behaves in many ways as an integral part of the central nervous system. As such, the eye-the optic nerve and retina-affords an ideal clinical model for neuroprotection and neuroprotective agents. Glaucomatous optic neuropathy is the most prevalent of all adult optic neuropathies, and offers an ideal primate and lower mammalian animal model for investigations of neuroprotection. Recent findings: This is especially compelling because while recent studies in glaucoma have shown reduction of intraocular pressure (IOP) to be an effective modality in the treatment of glaucomatous opt c neuropathy, not all patients respond to or can achieve meaningful IOP reductions. Therefore much attention has now been focused on neuroprotection as a strategy in therapies for glaucomatous optic neuropathy as a means of preserving retinal ganglion cells and their axonal projections. Summary: This review discusses the latest studies on various mechanisms of neuroprotection in the treatment of glaucomatous optic neuropathy.

KW - Apoptosis

KW - Axon

KW - Glaucoma

KW - Neurodegeneration

KW - Neuroprotection

KW - Neurorepair

KW - Neurorescue

KW - Neurorestoration

KW - Optic nerve

KW - Retinal ganglion cell

UR - http://www.scopus.com/inward/record.url?scp=1542407395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542407395&partnerID=8YFLogxK

U2 - 10.1097/00055735-200312000-00006

DO - 10.1097/00055735-200312000-00006

M3 - Article

C2 - 14615639

AN - SCOPUS:1542407395

VL - 14

SP - 353

EP - 356

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 6

ER -